⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
YDES News
YD Bio Limited Ordinary Shares
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
globenewswire.com
YDES
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
globenewswire.com
YDES
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
globenewswire.com
YDES
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
globenewswire.com
YDES